Bombali Virus in Mops condylurus Bat, Kenya
Kristian M. Forbes
1 , Paul W. Webala, Anne J. Jääskeläinen, Samir Abdurahman, Joseph Ogola, Moses M. Masika, Ilkka Kivistö, Hussein Alburkat, Ilya Plyusnin, Lev Levanov, Essi M. Korhonen, Eili Huhtamo, Dufton Mwaengo, Teemu Smura, Ali Mirazimi, Omu Anzala, Olli Vapalahti, and Tarja Sironen
Author affiliations: University of Helsinki, Helsinki, Finland (K.M. Forbes, A.J. Jääskeläinen, I. Kivistö, H. Alburkat, I. Plyusnin, L. Levanov, E.M. Korhonen, E. Huhtamo, T. Smura, O. Vapalahti, T. Sironen); Maasai Mara University, Narok, Kenya (P.W. Webala); Helsinki University Hospital, Helsinki (A.J. Jääskeläinen, O. Vapalahti); Public Health Agency of Sweden, Stockholm, Sweden (S. Abdurahman, A. Mirazimi); University of Nairobi, Nairobi, Kenya (J. Ogola, M.M. Masika, D. Mwaengo, O. Anzala); Karolinska University Hospital, Stockholm (A. Mirazimi); National Veterinary Institute, Uppsala, Sweden (A. Mirazimi)
Main Article
Figure 1
Figure 1. Locations of Bombali Ebola virus infection in Sierra Leone (gray shading at left; Bombali district in red) and Kenya (gray shading at right; Taita Hills area in green). Inset map shows collection site of the Bombali virus–positive bat (red dot) in Kenya, clinics in which human serum samples were collected (white squares), and the closest towns (black squares).
Main Article
Page created: April 18, 2019
Page updated: April 18, 2019
Page reviewed: April 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.